skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

The prevalence and clinical significance of inhalant withdrawal symptoms among a national sample

Original Research

(1953) Views  (225) Full article downloads

Authors: Perron BE, Glass JE, Ahmedani BK, Vaughn MG, Roberts DE, Wu LT

Published Date April 2011 Volume 2011:2(1) Pages 69 - 76
DOI: http://dx.doi.org/10.2147/SAR.S14937

Brian E Perron1, Joseph E Glass2, Brian K Ahmedani3, Michael G Vaughn4, Daniel E Roberts1, Li-Tzy Wu5
1University of Michigan, Ann Arbor, MI, USA; 2Washington University, St Louis, MO, USA; 3Henry Ford Health System, Detroit, MI, USA; 4St Louis University, St Louis, MO, USA; 5Duke University, Durham, NC, USA

Background: Inhalants are among the most common and dangerous forms of substance use, but very little research on inhalant use disorders exist. Unlike other substances, the Diagnostic and Statistical Manual, 4th edition (DSM-IV) indicates that inhalants do not have an associated withdrawal syndrome among persons who meet criteria for inhalant dependence.
Methods: Using data from the National Epidemiologic Survey on Alcohol and Related Conditions, this study examines the prevalence of withdrawal symptoms among inhalant users. Prevalence of inhalant withdrawal symptoms for inhalants was also compared with the prevalence of cocaine withdrawal symptoms to help determine the presence of an inhalant withdrawal syndrome.
Results: Approximately 47.8% of persons who met criteria for inhalant dependence reported experiencing three or more inhalant-related withdrawal symptoms that were clinically significant. Among those with inhalant dependence, almost half of the withdrawal symptoms were as common as the corresponding withdrawal symptoms experienced by persons with cocaine dependence. Furthermore, the percentage of persons with inhalant dependence reporting clinically significant inhalant withdrawal symptoms was almost equal to the percentage of persons with cocaine dependence reporting clinically significant cocaine withdrawal symptoms.
Conclusions: These data provide evidence for an inhalant-related withdrawal syndrome among persons with inhalant dependence. Revisions to DSM-IV should consider including inhalant withdrawal as a diagnostic criterion for this disorder.

Keywords: Inhalants, volatile solvents, withdrawal, inhalant use disorders






Readers of this article also read:

Nonlinear analysis of the heartbeats in public patient ECGs using an automated PD2i algorithm for risk stratification of arrhythmic death
Risk stratification for arrhythmic death in an emergency department cohort: a new method of nonlinear PD2i analysis of the ECG
Role of hydroxycarbamide in prevention of complications in patients with sickle cell disease
Substance abuse and rehabilitation: responding to the global burden of diseases attributable to substance abuse
Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease
Association of an overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis with cytomegalovirus infection
Successful treatment of reactive airways dysfunction syndrome by high-dose vitamin D
Against professional advice: treatment attrition among pregnant methamphetamine users
Phenotype characterization of embryoid body structures generated by a crystal comet effect tail in an intercellular cancer collision scenario
Letter to the editor